Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, February 16, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Yasmeen Rahimi Initiated (ANAB) at Buy and Held Target at $80 on, Feb 16th, 2024
Yasmeen Rahimi of Piper Sandler, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $80 on, Feb 16th, 2024.
Yasmeen has made no other calls on ANAB in the last 4 months.
There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, all agree with Yasmeen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Nierengarten of "Wedbush" Reiterated at Hold and Held Target at $20 on, Wednesday, November 29th, 2023
- Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $21 on, Thursday, November 2nd, 2023
